Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis - Report - MDSpire

Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis

  • By

  • Jesús Endara-Mina

  • Cristopher-Josue Escudero

  • Cesar Intriago

  • Lisseth Coloma-Ramirez

  • Wilson Cabrera

  • Rosa Gonzaga

  • Sebastian Fuentes

  • Dario Chicaiza

  • Carlos Carvajal

  • Rafael Lopez-Carrera

  • Belen Baño-Jimenez

  • Jordy Ruilova

  • Erick Atahualpa

  • Josue Aldaz

  • Mayuri Quishpe

  • Katherine Simbaña-Rivera

  • June 11, 2026

  • 0 min

Share

Clinical Report: Thromboembolic Events in Post-COVID Syndrome

Overview

This systematic review and meta-analysis investigates the prevalence of thromboembolic events in individuals with post-COVID syndrome. The findings indicate a significant thromboembolic risk, emphasizing the need for early detection and tailored preventive treatments.

Background

Post-COVID syndrome presents a growing challenge for healthcare systems, characterized by persistent symptoms following COVID-19 infection. One major concern is the potential for a prothrombotic state, which may lead to increased risks of thromboembolic events. Understanding this relationship is crucial for informing clinical management and monitoring strategies.

Data Highlights

The systematic review included 20 studies, with 5 contributing to quantitative synthesis, revealing significant thromboembolic risks among post-COVID syndrome patients.

Key Findings

  • Post-COVID syndrome is associated with a heterogeneous range of symptoms persisting beyond the acute phase of infection.
  • Individuals with post-COVID syndrome may experience an increased risk of venous and arterial thromboembolic events.
  • Elevated inflammatory markers and coagulation abnormalities during the acute phase may persist, contributing to thromboembolic risks.
  • Clinical manifestations of thromboembolic events can include myocardial infarction, ischemic stroke, and peripheral arterial occlusion.
  • Early detection and proactive monitoring are essential for managing thromboembolic risks in this population.

Clinical Implications

Healthcare providers should be vigilant in monitoring patients with post-COVID syndrome for thromboembolic events. Tailored preventive treatments, including anticoagulant therapy, may be necessary for at-risk individuals.

Conclusion

The findings highlight a significant thromboembolic risk in patients with post-COVID syndrome, necessitating further research and clinical attention.

Related Resources & Content

  1. ASH Guidelines on Use of Anticoagulation in Patients with COVID-19 - Hematology.org
  2. Frontiers | Associated Thromboembolic Events to the Post Covid Syndrome: A Systematic Review and Meta-Analysis
  3. Venous and arterial thromboembolic events after COVID-19 during the Omicron period in three European countries | Scientific Reports
  4. The ASCO Post — New Research Highlights Risk of Thromboembolic Complications in Patients With COVID-19
  5. The ASCO Post — New Research Highlights Risk of Thromboembolic Complications in Patients With COVID-19
  6. European Journal of Preventive Cardiology — Cardiovascular disease as part of Long COVID: a systematic review
  7. Open Forum Infectious Diseases — Worldwide Incidence of Long COVID, Its Variants, and Associated Risk Factors: A Comprehensive Systematic Review and Meta-Analysis
  8. New Research Highlights Risk of Thromboembolic Complications in Patients With COVID-19
  9. Cardiovascular disease as part of Long COVID: a systematic review
  10. ASH Guidelines on Use of Anticoagulation in Patients with COVID-19 - Hematology.org
  11. Frontiers | Associated Thromboembolic Events to the Post Covid Syndrome: A Systematic Review and Meta-Analysis
  12. Venous and arterial thromboembolic events after COVID-19 during the Omicron period in three European countries | Scientific Reports
  13. Frontiers | Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis
  14. European Respiratory Society statement on long COVID follow-up | European Respiratory Society

Original Source(s)

Related Content